Skip to main content
Premium Trial:

Request an Annual Quote

Slight Gain for BCW Index as Markets Recover

A week after the markets took a beating from investors, the BCW Index, along with blue chip and tech stocks, made gains for the week ended Tuesday. The BCW Index rose .6 percent, while the DJIA gained 2.5 percent and the Nasdaq rose 1.7 percent. The Nasdaq Biotech Index was flat for the tracking period.

Among the Index companies, Stratagene posted the biggest gain — 6.8 percent — as the firm's shares rebounded from a 52-week low of $5.65, reached on June 12. Applied Biosystems had a fairly strong week, finishing up 5.8 percent. Meanwhile, Bruker led decliners with a drop of 7 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(June 20, 2006)
Last Price
(June 13, 2006)
% change
Agilent
A
32.18
31.45
2.3
Applied Biosystems
ABI
30.50
28.84
5.8
Beckman
BEC
53.44
52.88
1.1
Bio-Rad
BIO
64.80
64.40
0.6
Bruker
BRKR
4.62
4.97
-7.0
Fisher Scientific
FSH
70.29
71.29
-1.4
GE
GE
33.70
33.73
-0.1
Harvard Bio
HBIO
4.09
4.16
-1.7
Invitrogen
IVGN
64.19
63.87
0.5
Molecular Devices
MDCC
28.42
27.85
2.0
PerkinElmer
PKI
20.40
20.55
-0.7
Qiagen
QGEN
13.20
12.98
1.7
Sigma
SIAL
70.03
68.89
1.7
Stratagene
STGN
6.25
5.85
6.8
Thermo
TMO
34.82
35.60
-2.2
Waters
WAT
41.66
41.82
-0.4
BCW Index Average
35.79
35.57
0.6
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.